Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Ovarian Cancer
Clinical trial register · Czechia

Ovarian Cancer Trials in Czechia, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Czechia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1529 matching records held by the registry are in this view. Synced 18 Nov 2026, 03:17 UTC
1529
Studies in scope
all four open statuses
792
Recruiting now
open to new participants
306
Lead sponsors
across recruiting studies
Top sites
Brno 2 Prague 2 Nový Jičín 1 Ostrava 1 Hradec Králové 1

Ovarian Cancer trials in Czechia

2 of 1529 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Czechia
Start
Active, closed
AbbVie
Phase 3
520
Brno, Prague, Nový Jičín, Ostrava
2023-03-15
Rows per page Showing 1–2 of 2
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Czech investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 November 2026. https://priyalifescience.com/clinical-trials-czechia/condition/ovarian-cancer

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Czechia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,529 studies in total at the last sync on 18 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2 of those studies listing the condition Ovarian Cancer that also match the filters currently applied.

How many Ovarian Cancer trials are recruiting in Czechia?

1 of the 2 studies on this page are recruiting new participants as of the 18 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ovarian Cancer), 2 studies
PhaseStudiesRecruitingShare
Phase 21150%
Phase 31050%

Most active sponsors

Lead sponsors with the most studies (Ovarian Cancer)
Lead sponsorStudiesRecruiting
AbbVie21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.